Skip to content
value.today

GX Molecular Inc.

Total raised
$15 M
1 round on record
Latest round
$15 M
Sep 2022
First round on record
Sep 2022
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of GX Molecular Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2022$15 MNo. 1$10 to $50 million

GX Molecular Inc.: Raise no. 1, Sep 2022

Investors in this round

17 investors had bought by the notice of Sep 20, 2022: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $20 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeremy Dickinson Preston · Executive Officer
  • Lucas Edelman · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Actual Total Offering Amount: $20,016,226.49; Actual Total Amount Sold: $14,546,227.18; Actual Total Amount Remaining to be Sold: $5,469,999.31”

Signed by Lucas Edelman, Chief executive officer. Source: SEC Form D, newest notice filed Sep 20, 2022. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • GX Molecular Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2022).

    SEC Form D · Sep 2022

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Sep 2022

That is all the official record says: GX Molecular Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of GX Molecular Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 17 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by GX Molecular Inc.
NameRoleNamed in
Jeremy Dickinson PrestonExecutive officerSep 2022
Lucas EdelmanExecutive officerSep 2022
Lucas EdelmanDirectorSep 2022